🇺🇸 FDA
Patent

US 11911359

Stimulation of an immune response by cationic lipids

granted A61KA61K2039/55555A61K31/14

Quick answer

US patent 11911359 (Stimulation of an immune response by cationic lipids) held by PDS Biotechnology Corporation expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PDS Biotechnology Corporation
Grant date
Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/55555, A61K31/14, A61K31/20, A61K31/231